Archived Seminar: Design and Optimization of CAR T cells and their Application to Glioblastoma
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Design and Optimization of CAR T Cells and Their Application to Glioblastoma
Date: Sept. 18, 2020
Time: 11:00 a.m. - 12:00 p.m.
Abstract
Encouraging clinical experience with chimeric antigen receptor (CAR) T cells supports the notion that even immune privileged sites such as the brain may be amenable to CAR therapy. In the context of hematologic B-cell malignancies, CD19-CARs have been shown to accumulate in the cerebrospinal fluid (CSF) and reduce the incidence of metastatic disease in the central nervous system. However, brain tumors pose significant challenges for CAR T cell therapy, including heterogeneous antigen expression, immunosuppressive networks in the tumor microenvironment that limit CAR T cell function and persistence, and suboptimal T cell trafficking to the tumor site. This presentation will describe our clinical experience with CAR T cells for glioblastoma (GBM), one of the most common and aggressive primary malignant brain tumors, and our efforts to overcome therapeutic challenges.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home ItemBlood-Based Approaches to Counter Aging , home
Jan. 31, 2025, 11:00 a.m. | Saul Villeda, Ph.D., Associate Professor, Chair, Department of Biomedical Science, University of California, San Francisco | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemDisability Identity, Inclusivity & Representation in Research , home
Feb. 14, 2025, 11:00 a.m. | Anjali Forber-Pratt, Ph.D., Director of Research, American Association on Health and Disability | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemHow Big Med Drives Rising Healthcare Costs and What to Do About It , home
Feb. 20, 2025, 5:30 p.m. (Reception at 5 p.m.) | Vivian Ho, Ph.D., James A. Baker III Institute Chair in Health Economics, Baker Institute for Public Policy, Rice University | Maury Strauss Distinguished Public Lecture
-
Home ItemAddictive Nicotine and Stress Induce Convergent Mechanisms That Increase Alcohol Self‐administration , home
Feb. 21, 2025, 11:00 a.m. | John Dani, Ph.D., Professor of Neurological Sciences, Chair, Department of Neuroscience, Scientific Director, UPENN, CNS Consortium, Perlman School of Medicine, University of Pennsylvania | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
-
Home ItemExploring the Functional Role of Gene Variation in Nicotine and Alcohol Abuse , home
Feb. 21, 2025, 1 p.m. | Mariella De Biasi, Ph.D., Professor, Director, Program for Cholingeric Mechanisms in Addiction, Perlman School of Medicine, University of Pennsylvania | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
Christine Brown, Ph.D.
Professor in the Department of Hematology and Hematopoietic Cell Transplantation; Heritage Provider Network Professor in Immunotherapy; and Deputy Director of the T Cell Therapeutics Research Laboratory, at City of Hope